SpringWorks Therapeutics’ stock jumps after FDA approves first treatment for rare type of aggressive tumors

SpringWorks shares jumped early Tuesday after regulatory approval for tumor treatment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.